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Pathophysiology
•
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Asthma is characterized by two
interrelated abnormalities: airway
inflammation and airway hyperresponsiveness. This disease is
heterogeneous and chronic, with
acute exacerbations (Donahue and
Jain 2013, p 944).
Triggers for the airway inflammation
and hyper-responsiveness that
occurs with asthma include; exercise
and numerous exogenous factors
such as aeroallergens, infections,
cigarette smoke and other irritants.
Airway inflammation results from
the activation of mast cells and
antigen-specific Th2 cells, resulting in
the production of cytokines,
including interleukin (IL)-4, IL-5 and
IL-13 (Donahue and Jain 2013, p
945).
During an acute asthma exacerbation
or, “attack”, a trigger is encountered
and causes the airways to restrict
and become narrow leading to
hypoxia, hypercapnia, and acidosis.
Airway occlusion results from
smooth muscle bronchoconstriction,
airway edema and inflammation. In
addition to less air passing in and out
of the lungs, excess mucus
accumulates in the airway further
impeding proper gas exchange
(Dhankani, Girase, Chavan, & Pawar
S. 2013, p 413).
Causes of asthma are multifactorial
and are influenced by both
environmental and genetic causes.
Allergic inflammation is well known
to be a causative factor contributing
to this disease. Asthma is influenced
by inflammatory molecules such as
Interleukin 6 (IL-6) (Nakajima et al
2017, p 125).
The Johns Hopkins Asthma and
Allergy Center conducted a study
that found that between 85 and 95%
of patients with asthma had allergic
rhinitis (Khan 2014, p 358).
Genetics play a distinct role in the
patient’s susceptibility to developing
asthma (Melen and Pershagen 2012,
p 117).
Asthma is thought to be influenced
by alterations in the microbiome of
the lungs. Further research regarding
the microbiota in asthmatic patients
may lead to exciting new
developments in asthma
interventions (Sullivan et al. 2016, p
1).

Signs and Symptoms of Acute Asthma
Exacerbation
Airway inflammation can lead to the
following clinical presentation:

•

•

•

•
•
•
•
•
•

Dyspnea
Cough
Chest tightness
Wheezing
Airflow obstruction
Any combination of these
symptoms

•

Evaluation of peak flow may be
useful during asthma
exacerbation, but only if
patient’s individualized peak
flow baseline is current and
known during the time of
treatment (Fanta 2017, p 1).
An asthma exacerbation can usually
be presented in the clinical setting
under one of two subcategories;
severe, or respiratory arrest
imminent.
Severe: characterized by dyspnea at
rest that interferes with
conversation, peak expiratory flow
rate (PEFR) <40% predicted, usually
requires emergency department (ED)
visit and likely hospitalization.
Patient experiences partial relief
from frequent inhaled short-acting
beta-agonists
Respiratory Arrest Imminent: Patient
is too dyspneic to speak; sweating,
PEFR <25% predicted, requires
ED/hospitalization; possible ICU,
minimal or no relief from frequent
inhaler, intravenous corticosteroids,
and/or adjunctive therapies.

Introduction
Asthma is a chronic respiratory
disorder that affects over 300 million
people worldwide.
This disorder is characterized by airway
hyper-responsiveness and
inflammation.
Asthma is seen in patients across the
lifespan.
Asthma continues to increase in
prevalence and is one of the most
common lung disorders seen and
treated in the healthcare setting
(Fehrenbach, Wagner, and Wegmann
2017, p 551).
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The original presentation or development
of asthma may occur in children or adults
Acute asthma exacerbation may be
gradual or sudden in onset, depending on
the phenotype (Restrepo, et al, p 534).
be seen in pediatric patients, or it may
have a new onset in adulthood.
Effective management is multi-factorial
This topic was chosen due to it’s relevance
in the healthcare setting, and applicability
to the practice of the APN.
APN’s must understand and be prepared
to encounter this common illness.

Nursing Implications
•

•

•
•
•
•
•
•
•
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Red flags of impending respiratory failure:
•
•
•

Tachypnea
Tachycardia
Use of accessory muscles

•

The presence of pulsus
paradoxus in patients with
acute severe asthma is an
indication of ventilatory muscle
fatigue and impending
respiratory failure (Restrepo, et
al, p 523).
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Use of mechanical ventilation is
indicated when other therapies
fail to improve the patient’s
symptoms and the patient has
had a decrease in respiratory
effort, change in mental status,
or exhibits hypercapnia and
respiratory acidosis (Fanta
2017, p 6).

•

Presence of strong assessment skills in order to recognize this
condition and intervene appropriately. Ability to identify
abnormal lung sounds and recognize respiratory difficulty or
distress.
Facilitate communication with interdisciplinary care team as
needed (i.e. Respiratory therapy). Other disciplines, such as
radiology or laboratory, may be involved as well depending on
presentation of the patient and physician’s orders.
Be knowledgeable regarding potential therapeutic interventions:
Positioning patient
Use of oxygen and oxygen delivery methods
Use of nebulizer, inhaler and spacer device.
Oxygen titrated to maintain SpO2 of >92%.
Selective beta 2 agonists Antimuscarinics
Corticosteroids
Magnesium sulfate when indicated (Hazeldine 2013, p 48).
The nurse should be knowledgeable regarding potential side
effects or adverse effects of the administered medications,
such as tachycardia in response to inhaled albuterol.
Educating patients on the following:
Risk factors
Avoidance of triggers
Proper use of rescue inhaler
Spacer use
Asthma action plan
Smoking cessation and/or second hand smoke avoidance
When to seek emergency medical care during an acute attack
Understanding of peak flow meter use and interpretation
In severe cases, the nurse must be prepared for, and
understand their role in, either non-invasive ventilation or
invasive ventilation (intubation) of the patient.
The patient should be kept NPO during the acute phase in
order to prevent potential aspiration in the event of
endotracheal intubation.

Conclusion
•

Significance of Pathophysiology
•

•
•
•

Asthma is thought to have two phenotypes; gradual onset and sudden onset.
Depending on the phenotype, the response to interventions may be different. For
example, in gradual onset there is mucus plugging in the airway, and a slower
response to treatment. Sudden onset typically does not have mucus plugging, and
responds more rapidly to treatment (Restrepo, et al, p 522). This is one example of
why understanding the complex pathophysiological processes is crucial when
diagnosing and treating patients.
Understanding the pathophysiology of asthma supports the ability to prevent acute
attacks by avoiding triggers, or intervening early when symptoms begin.
Early recognition and treatment of acute asthma exacerbation has direct effect on
morbidity and mortality in these patients.
Understanding of the physiologic process occurring in asthmatic patients is critical in
order to understand how therapeutic interventions impact the patient’s disease
process.

•
•
•

•
•

Thorough and effective patient education is a key factor in
preventing an acute exacerbation of asthma.
Early intervention for patients experiencing acute asthma
exacerbation is critical for positive outcomes.
With proper management and evidence based practice, mortality
for patient’s with mild to moderate acute asthma exacerbation is
low.
However, approximately 10 to 30% of patients may still require
positive pressure ventilation for severe acute asthma and mortality
could be as high as 22% (Restrepo, et al, p532).
Recognizing the signs and symptoms quickly will assist the APN in
initiating the appropriate treatments in a timely manner.
Although Asthma has the ability to produce severe acute
exacerbations that may become life threatening, this chronic illness
can be properly managed with proper trigger/allergen
identification, maintenance medications, asthma action plan, and
periodic monitoring of the patient’s respiratory status using peak
flow.
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